Anti-vaxxer's adult son contracts measles and says parents today have 'no excuse' to not vaccinate

Joshua Neris, 30, from Chicago, Illinois, contracted measles in May 2016 while attending his sister's graduation. He learned while he was at the hospital that he wasn't vaccinated as a child.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Vincent and Rich return to the University of Texas Medical Branch at Galveston to speak with Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver about their work on viruses transmitted by mosquitoes and ticks. Hosts: Vincent Racaniello and Rich Condit Guests: Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Measles virus vectored chikungunya vaccine (J Inf Dis) World Reference Center for Emerging Viruses and Arboviruses Insect-specific alphavirus vaccine vect...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts
CONCLUSION: Our results demonstrated lower than expected seroprotection against measles among vaccinated children. Understanding the factors that affect host immunity to measles will aid in developing more efficient and effective immunization programs in DRC. PMID: 32057333 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
This NIHR Signal pooled data from 56 studies and found that the vaccine is around 58% effective when administered before nine months compared with 83% after nine months.With measles on the rise in Europe and the UK, it is helpful to know that in the event of a measles outbreak, it could be used safely in younger infants as an additional measure.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
This House of Lords Library Briefing focuses on the measles, mumps and rubella (MMR) jab. It looks at social media's role in the spread of misinformation, what the UK Government and social media companies have pledged to do about it, and what other countries are doing to solve declining rates of MMR vaccination.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
.
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research
Conclusions: Our study revealed heterogeneity across HDs' mumps outbreak responses but also identified common challenges that will inform future Centers for Disease Control and Prevention guidance. These results were considered in the October 2017 Advisory Committee on Immunization Practices recommendation for use of a third dose of MMR vaccine for persons at increased risk for mumps during an outbreak and in the development of Centers for Disease Control and Prevention guidance for HDs when applying the Advisory Committee on Immunization Practices recommendation.
Source: Journal of Public Health Management and Practice - Category: Health Management Tags: Research Reports: Practice Full Report Source Type: research
Conclusion: This guidance provides a framework for public health authorities to use when considering a third dose of MMR in response to mumps outbreaks while maintaining flexibility to incorporate local factors related to individual outbreaks.
Source: Journal of Public Health Management and Practice - Category: Health Management Tags: Research Reports: Practice Full Report Source Type: research
.
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research
The WHO has singled out the need to earn the public ’s trust with respect to vaccinations. This requires education, positive messaging, and a willingness to confront and debate the anti-vax community civilly and respectfully in a public setting.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Abstract Measles outbreaks occur periodically in remote and difficult to reach areas in countries such as the Democratic Republic of Congo. The possibility to keep measles vaccines at temperatures outside the cold chain for a limited period prior to administration would be an advantage for organizations such as Médecins Sans Frontières, which repeatedly respond to measles outbreaks in difficult contexts. Using stability data at 37 °C and 40 °C provided by Serum Institute of India Private Limited we applied the product release model for Extended Controlled Temperature Conditions (ECT...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
More News: Children | Contracts | Graduation | Health | Hospitals | Measles | Measles Vaccine | Vaccines